CTTI Mobile Tech Recommendations Featured in New Digital Biomarkers Article

The open access journal Digital Biomarkers published a new article this week featuring CTTI recommendations for the use of Mobile Technologies for Data Capture and Improved Clinical Trials. The article articulates the vision of using mobile technologies in clinical trials and highlights CTTI’s evidence-based solutions for using mobile technologies for more efficient assessment of new therapies for patients.

Mobile technologies such as wearables, ingestibles, implantables, portable sensors, and smartphones are designed to collect measures directly from an individual and could potentially contribute to a more complete picture of a patient’s experience in a clinical trial. This article offers recommendations for technology selection, data collection, analysis and interpretation, data management, protocol design and execution, and FDA submission and inspection.